Schedule 13D ownership disclosure
ACHILLES THERAPEUTICS PLC
Security class unavailable · CUSIP: 00449L102
Event date: 2022-12-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,976,943
- Percent of class
- 7.2700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-129939
- Form type
- SC 13D
- Filer
- Achilles Therapeutics plc
- CIK
- CIK 1830749
- Filed
- Dec 23, 2022
- Reporting period
- Dec 21, 2022
- Description
- Schedule 13D beneficial ownership